Clinical Trial Update: Efficacy, Safety and Pharmacokinetics of Artemether-lumefantrine Dispersible Tablet in the Treatment of Malaria in Infants < 5 kg [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial update assessing the efficacy, safety, and pharmacokinetics of an artemether-lumefantrine dispersible tablet for treating acute…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plasmodium Falciparum Malaria

Drugs mentioned

• Artemether-lumefantrine dispersible tablet (artemether-lumefantrine)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Acute Uncomplicated Falciparum Malaria | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2015-06-17